57 results
8-K
EX-4.2
ZOM
Zomedica Corp
13 Feb 20
Zomedica Announces $2.5 Million Registered Direct Offering
12:00am
from the Holder by paying to the Holder an amount of cash equal to the Black Scholes Value (as defined below) of the remaining unexercised portion … Successor Entity the same type or form of consideration (and in the same proportion), at the Black Scholes Value of the unexercised portion of this Warrant
10-K
2017 FY
EX-10.23
ZOM
Zomedica Corp
28 Feb 18
Annual report
12:00am
effecting such registration. Subject to any permitted “Black-Out Periods” (as described below), Zomedica shall use its commercially reasonable efforts … of such periods is referred to herein as a “Black-Out Period.” Except for any Black-Out Period arising pursuant to clause (i) above, no Black-Out
8-K
EX-4.1
ZOM
Zomedica Corp
13 Feb 20
Zomedica Announces $2.5 Million Registered Direct Offering
12:00am
an amount of cash equal to the Black Scholes Value (as defined below) of the remaining unexercised portion of this Warrant on the date … of consideration (and in the same proportion), at the Black Scholes Value of the unexercised portion of this Warrant, that is being offered and paid
8-K
EX-4.1
ZOM
Zomedica Corp
6 Jul 20
Zomedica Pharmaceuticals Corp. Announces Proposed Public Offering
5:18pm
to the Holder an amount of cash equal to the Black Scholes Value (as defined below) of the remaining unexercised portion of this Warrant on the date … or form of consideration (and in the same proportion), at the Black Scholes Value of the unexercised portion of this Warrant, that is being offered and paid
8-K
EX-4.2
v3qzv9g6kvvn16d
8 Apr 20
Zomedica Pharmaceuticals Corp. Announces Public Offering
4:40pm
8-K
EX-4.1
6mynuwzerb7c3 gpx9as
8 Apr 20
Zomedica Pharmaceuticals Corp. Announces Public Offering
4:40pm
424B3
zq9zia8
9 Aug 18
Prospectus supplement
4:16pm